No profile data available.
Cognetivity Neurosciences Ltd. (CGNSF) is a healthcare company in the additional medical support operations industry, based in Vancouver, Canada.
It reported revenue of $45,366 for fiscal year 2023, and net income of -$7.43 million. In Q3 2024 (the quarter ended October 31, 2023) revenue was $29,156. Its market capitalization was $8,958 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended January 31, 2023; market data as of October 8, 2026.
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp.
Cognetivity Neurosciences reported $45,366 in revenue for fiscal year 2023. In Q3 2024 revenue was $29,156.
$8,958 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional medical support operations) include Natural Health Farm Holdings Inc. (NHEL), Binovi Technologies Corp. (BNVIF), OneLife Technologies Corp. (OLMM), Accelera Innovations, Inc (ACNV).